Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
letter
. 1994 Mar;69(3):622–623. doi: 10.1038/bjc.1994.117

Soluble IL-2 alpha and ovarian cancer.

D P Barton
PMCID: PMC1968877  PMID: 8123502

Full text

PDF

Page 622

622

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barton D. P., Blanchard D. K., Michelini-Norris B., Nicosia S. V., Cavanagh D., Djeu J. Y. High serum and ascitic soluble interleukin-2 receptor alpha levels in advanced epithelial ovarian cancer. Blood. 1993 Jan 15;81(2):424–429. [PubMed] [Google Scholar]
  2. Kamio M., Arima N., Tsudo M., Imada K., Ohkuma M., Uchiyama T. The third molecule associated with interleukin 2 receptor alpha and beta chain. Biochem Biophys Res Commun. 1992 May 15;184(3):1288–1292. doi: 10.1016/s0006-291x(05)80022-1. [DOI] [PubMed] [Google Scholar]
  3. Owens O. J., Taggart C., Wilson R., Walker J. J., McKillop J. H., Kennedy J. H. Interleukin-2 receptor and ovarian cancer. Br J Cancer. 1993 Aug;68(2):364–367. doi: 10.1038/bjc.1993.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Takeshita T., Asao H., Ohtani K., Ishii N., Kumaki S., Tanaka N., Munakata H., Nakamura M., Sugamura K. Cloning of the gamma chain of the human IL-2 receptor. Science. 1992 Jul 17;257(5068):379–382. doi: 10.1126/science.1631559. [DOI] [PubMed] [Google Scholar]
  5. Taniguchi T., Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell. 1993 Apr 9;73(1):5–8. doi: 10.1016/0092-8674(93)90152-g. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES